Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VICE vs Standard Chemotherapy in Limited Stage Small Cell Lung Cancer
NCT00002822Phase 3Completed
- Sponsor
- Medical Research Council
- Start
- Mar 1996
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin, ifosfamide, etoposide, vincristine in small cell lung cancer (SCLC), sponsored by Medical Research Council. Started Mar 1996; status: completed.
02
Drugs
carboplatinifosfamideetoposidevincristine
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00002822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002822.